Cargando…
Anti-PD-L1 monoclonal antibody for the management of chronic disseminated intravascular coagulation secondary to a urothelial carcinoma: a case report
BACKGROUND: Thrombocytopenia is often considered a risk factor for bleeding, but conversely may be associated with an increased thrombotic risk in several clinical situations. Here we present a patient with arterial thrombosis and chronic disseminated intravascular coagulation caused by metastatic u...
Autores principales: | Maiorano, Silvia, Gulden-Sala, Wiebke, Gerber, Bernhard, Ghilardi, Guido |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8935767/ https://www.ncbi.nlm.nih.gov/pubmed/35307010 http://dx.doi.org/10.1186/s13256-022-03338-2 |
Ejemplares similares
-
Disseminated intravascular coagulation
por: Venugopal, A
Publicado: (2014) -
Sepsis and disseminated intravascular coagulation
por: Okamoto, Kohji, et al.
Publicado: (2016) -
Disseminated intravascular coagulation or extended intravascular coagulation in massive pulmonary embolism
por: LEVI, M
Publicado: (2010) -
Disseminated Intravascular Coagulation with Enhanced Fibrinolysis Caused by Heart Metastasis of Bladder Urothelial Carcinoma
por: Helal, Clara, et al.
Publicado: (2022) -
Exploring the epidemiology of disseminated intravascular coagulation: protocol for the DANish Disseminated Intravascular Coagulation (DANDIC) Cohort Study
por: Flæng, Simon, et al.
Publicado: (2022)